G

Gubra A/S
CSE:GUBRA

Watchlist Manager
Gubra A/S
CSE:GUBRA
Watchlist
Price: 614 DKK 0.66% Market Closed
Market Cap: 10B DKK
Have any thoughts about
Gubra A/S?
Write Note

Relative Value

The Relative Value of one GUBRA stock under the Base Case scenario is 114.8 DKK. Compared to the current market price of 614 DKK, Gubra A/S is Overvalued by 81%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GUBRA Relative Value
Base Case
114.8 DKK
Overvaluation 81%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
23
vs Industry
7
Median 3Y
12.9
Median 5Y
12.9
Industry
4.1
vs History
vs Industry
0
Median 3Y
-245
Median 5Y
-245
Industry
32.7
vs History
vs Industry
3
Median 3Y
-448.9
Median 5Y
-448.9
Industry
22.1
vs History
vs Industry
0
Median 3Y
-173.9
Median 5Y
-173.9
Industry
33.6
vs History
23
vs Industry
2
Median 3Y
5.5
Median 5Y
5.5
Industry
2.6
vs History
23
vs Industry
7
Median 3Y
11
Median 5Y
11
Industry
3.9
vs History
23
vs Industry
6
Median 3Y
19.5
Median 5Y
19.5
Industry
8.6
vs History
vs Industry
0
Median 3Y
-216.6
Median 5Y
-216.6
Industry
18.5
vs History
vs Industry
Median 3Y
-216.6
Median 5Y
-216.6
Industry
23.7
vs History
vs Industry
4
Median 3Y
-434.4
Median 5Y
-434.4
Industry
21.4
vs History
vs Industry
2
Median 3Y
-219.2
Median 5Y
-219.2
Industry
28.8
vs History
23
vs Industry
0
Median 3Y
15.5
Median 5Y
15.5
Industry
2.4

Multiples Across Competitors

GUBRA Competitors Multiples
Gubra A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Gubra A/S
CSE:GUBRA
10B DKK 44.7 -215.2 -189.4 -189.4
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
67T KRW 15.4 63.7 34.5 49.6
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
162B CNY 4.2 20.2 14.6 14.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
G
Gubra A/S
CSE:GUBRA
Average EV/EBITDA: 177.5
Negative Multiple: -189.4
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 538.7
23%
67.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.4
19%
1.1
US
Danaher Corp
NYSE:DHR
26.9
22%
1.2
KR
Samsung Biologics Co Ltd
KRX:207940
34.5
57%
0.6
CH
Lonza Group AG
SIX:LONN
45.3
36%
1.2
US
Agilent Technologies Inc
NYSE:A
22.4
34%
0.7
US
IQVIA Holdings Inc
NYSE:IQV
14.2
32%
0.4
US
Mettler-Toledo International Inc
NYSE:MTD
24.3
16%
1.5
US
West Pharmaceutical Services Inc
NYSE:WST
32.4
16%
2
CN
WuXi AppTec Co Ltd
SSE:603259
14.6
52%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
G
Gubra A/S
CSE:GUBRA
Average EV/EBIT: 357.5
Negative Multiple: -189.4
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
3 279.1
130%
25.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
30.6
57%
0.5
US
Danaher Corp
NYSE:DHR
40.4
59%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
49.6
76%
0.7
CH
Lonza Group AG
SIX:LONN
45.3
37%
1.2
US
Agilent Technologies Inc
NYSE:A
26.1
42%
0.6
US
IQVIA Holdings Inc
NYSE:IQV
21.7
70%
0.3
US
Mettler-Toledo International Inc
NYSE:MTD
27.2
22%
1.3
US
West Pharmaceutical Services Inc
NYSE:WST
40.7
13%
3.2
CN
WuXi AppTec Co Ltd
SSE:603259
14.6
23%
0.6

See Also

Discover More
Back to Top